Oncology News From March 17, 2022

FDA Clearance to Proceed with Ph 1b/2 Trial of ADG126 SAFEbody® in Combination with Pembrolizumab Announced

March 17, 2022

Our previous campaigns

April 28, 2026 Onco-This-Week Newsletter April 28, 2026
April 21, 2026 Onco-This-Week Newsletter April 21, 2026
April 15, 2026 Onco-This-Week Newsletter April 15, 2026
April 7, 2026 Onco-This-Week Newsletter April 07, 2026
March 31, 2026 Onco-This-Week Newsletter March 31, 2026
March 24, 2026 Onco-This-Week Newsletter March 24, 2026
March 17, 2026 Onco-This-Week Newsletter March 17, 2026
March 10, 2026 Onco-This-Week Newsletter March 10, 2026
March 3, 2026 Onco-This-Week Newsletter March 03, 2026
February 25, 2026 Onco-This-Week Newsletter February 25, 2026
February 17, 2026 Onco-This-Week Newsletter February 17, 2026
February 9, 2026 Onco-This-Week Newsletter February 9, 2026
February 2, 2026 Onco-This-Week Newsletter February 2, 2026
January 26, 2026 Onco-This-Week Newsletter January 25, 2026
January 25, 2026 Onco-This-Week Newsletter January 18, 2026
January 22, 2026 Onco-This-Week Newsletter January 22, 2026
January 21, 2026 Onco-This-Week Newsletter January 21, 2026
December 23, 2025 Onco-This-Week Newsletter December 23, 2025
December 16, 2025 Onco-This-Week Newsletter December 16, 2025
December 9, 2025 Onco-This-Week Newsletter December 09, 2025
December 2, 2025 Onco-This-Week Newsletter December 02, 2025
November 25, 2025 Onco-This-Week Newsletter November 25, 2025
November 18, 2025 Onco-This-Week Newsletter November 18, 2025
November 10, 2025 Onco-This-Week Newsletter November 10, 2025
November 4, 2025 Onco-This-Week Newsletter November 04, 2025
October 29, 2025 Onco-This-Week Newsletter October 29, 2025